States may need to tweak generic drug laws to increase access, researchers find
Over the years, more than 30 states have adopted new laws requiring patient consent or notification for pharmacists before cheaper generic meds could be provided to patients. But a group of 3 Harvard researchers says the barrier is high enough to steer patients toward more expensive drugs, and they want the legal barricades dismantled.
To improve use of these inexpensive and equally effective generic alternatives, three researchers from Harvard are calling for laws to be amended in 39 states plus Washington, DC, that require such patient consent or notification for generic substitution.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.